{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:40:33Z","timestamp":1793497233163,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-03043-6","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:05:45Z","timestamp":1770102345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of atherogenic index of plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018"],"prefix":"10.1186","volume":"25","author":[{"given":"Chaojie","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"4","key":"3043_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004.","journal-title":"Hepatology"},{"issue":"4","key":"3043_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338. https:\/\/doi.org\/10.1038\/s41575-020-00381-6. Epub 2020 Dec 21.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"3043_CR3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34(7):969\u2013e9772. https:\/\/doi.org\/10.1016\/j.cmet.2022.05.003. Epub 2022 Jun 3.","journal-title":"Cell Metab"},{"issue":"8","key":"3043_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739\u201352. https:\/\/doi.org\/10.1016\/S2468-1253(20)30077-7. Epub 2020 May 12.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"40","key":"3043_CR5","doi-asserted-by":"publisher","first-page":"e45051","DOI":"10.1097\/MD.0000000000045051","volume":"104","author":"Y Luo","year":"2025","unstructured":"Luo Y, Wang L, Yang X, Zhu L. NAFLD in adolescents aged 10\u201319: global burden of disease analysis from 1990 to 2021. Med (Baltim). 2025;104(40):e45051. https:\/\/doi.org\/10.1097\/MD.0000000000045051.","journal-title":"Med (Baltim)"},{"issue":"6","key":"3043_CR6","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. Epub 2023 Jun 24.","journal-title":"J Hepatol"},{"issue":"9","key":"3043_CR7","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res. 2023;119(9):1787\u201398. https:\/\/doi.org\/10.1093\/cvr\/cvad095.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"3043_CR8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and Pharmacological implications. Gut. 2020;69(9):1691\u2013705. https:\/\/doi.org\/10.1136\/gutjnl-2020-320622.","journal-title":"Gut"},{"issue":"11","key":"3043_CR9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(11):903\u201313. https:\/\/doi.org\/10.1016\/S2468-1253(21)00308-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"17","key":"3043_CR10","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S, et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021;385(17):1559\u201369. https:\/\/doi.org\/10.1056\/NEJMoa2029349.","journal-title":"N Engl J Med"},{"issue":"8","key":"3043_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707. https:\/\/doi.org\/10.1016\/j.tem.2024.02.007.","journal-title":"Trends Endocrinol Metab"},{"key":"3043_CR12","doi-asserted-by":"publisher","first-page":"i2416","DOI":"10.1136\/bmj.i2416","volume":"353","author":"JA Damen","year":"2016","unstructured":"Damen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ. 2016;353:i2416. https:\/\/doi.org\/10.1136\/bmj.i2416.","journal-title":"BMJ"},{"issue":"1","key":"3043_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. https:\/\/doi.org\/10.1186\/s12933-018-0762-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3043_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8. https:\/\/doi.org\/10.1186\/s12933-023-02115-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3043_CR15","doi-asserted-by":"publisher","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, the American Heart Association\/American Stroke Association. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From. Stroke. 2021;52(7):e364-e467. doi: 10.1161\/STR.0000000000000375. Epub 2021 May 24. Erratum in: Stroke. 2021;52(7):e483-e484. https:\/\/doi.org\/10.1161\/STR.0000000000000383","DOI":"10.1161\/STR.0000000000000383"},{"issue":"3","key":"3043_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/jamaneurol.2021.5080","volume":"79","author":"S Koton","year":"2022","unstructured":"Koton S, Pike JR, Johansen M, Knopman DS, Lakshminarayan K, Mosley T, et al. Association of ischemic stroke Incidence, Severity, and recurrence with dementia in the atherosclerosis risk in communities cohort study. JAMA Neurol. 2022;79(3):271\u201380. https:\/\/doi.org\/10.1001\/jamaneurol.2021.5080.","journal-title":"JAMA Neurol"},{"issue":"10","key":"3043_CR17","doi-asserted-by":"publisher","first-page":"e039387","DOI":"10.1161\/JAHA.124.039387","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Long Z, Liu P, Qin Q, Yuan H, Cao Y, et al. Global burden and risk factors of stroke in young Adults, 1990 to 2021: A systematic analysis of the global burden of disease study 2021. J Am Heart Assoc. 2025;14(10):e039387. https:\/\/doi.org\/10.1161\/JAHA.124.039387. Epub 2025 May 15.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"3043_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","volume":"23","author":"GBD 2021 Stroke Risk Factor Collaborators","year":"2024","unstructured":"GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and National burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet Neurol. 2024;23(10):973\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(24)00369-7.","journal-title":"Lancet Neurol"},{"issue":"3","key":"3043_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3350\/cmh.2022.0155","volume":"28","author":"Q Jin","year":"2022","unstructured":"Jin Q, Yang RX, Fan JG. Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke? Clin Mol Hepatol. 2022;28(3):473\u20137. https:\/\/doi.org\/10.3350\/cmh.2022.0155. Epub 2022 Jun 22.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"3043_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","volume":"52","author":"J Xu","year":"2021","unstructured":"Xu J, Dai L, Zhang Y, Wang A, Li H, Wang Y, et al. Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events. Stroke. 2021;52(1):103\u201310. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030433. Epub 2020 Dec 4.","journal-title":"Stroke"},{"issue":"3","key":"3043_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3350\/cmh.2021.0406","volume":"28","author":"ASP Tang","year":"2022","unstructured":"Tang ASP, Chan KE, Quek J, Xiao J, Tay P, Teng M, et al. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals. Clin Mol Hepatol. 2022;28(3):483\u201396. https:\/\/doi.org\/10.3350\/cmh.2021.0406. Epub 2022 Mar 2.","journal-title":"Clin Mol Hepatol"},{"key":"3043_CR22","doi-asserted-by":"publisher","unstructured":"Li H, Hu B, Wei L, Zhou L, Zhang L, Lin Y et al. Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions. Eur J Neurol. 2018;25(3):577-e34. https:\/\/doi.org\/10.1111\/ene.13556. Epub 2018 Jan 18.","DOI":"10.1111\/ene.13556"},{"issue":"1","key":"3043_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK biobank. Cardiovasc Diabetol. 2025;24(1):12. https:\/\/doi.org\/10.1186\/s12933-024-02572-w.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3043_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1sov\u00e1","year":"2001","unstructured":"Dobi\u00e1sov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583\u20138. https:\/\/doi.org\/10.1016\/s0009-9120(01)00263-6.","journal-title":"Clin Biochem"},{"issue":"1","key":"3043_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12933-024-02359-z","volume":"23","author":"M Qin","year":"2024","unstructured":"Qin M, Chen B. Association of atherogenic index of plasma with cardiovascular disease mortality and all-cause mortality in the general US adult population: results from NHANES 2005\u20132018. Cardiovasc Diabetol. 2024;23(1):255. https:\/\/doi.org\/10.1186\/s12933-024-02359-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3043_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12944-020-01208-8","volume":"19","author":"Q Guo","year":"2020","unstructured":"Guo Q, Zhou S, Feng X, Yang J, Qiao J, Zhao Y, et al. The sensibility of the new blood lipid indicator\u2013atherogenic index of plasma (AIP) in menopausal women with coronary artery disease. Lipids Health Dis. 2020;19(1):27. https:\/\/doi.org\/10.1186\/s12944-020-01208-8.","journal-title":"Lipids Health Dis"},{"key":"3043_CR27","doi-asserted-by":"publisher","first-page":"1140215","DOI":"10.3389\/fcvm.2023.1140215","volume":"10","author":"Y Li","year":"2023","unstructured":"Li Y, Feng Y, Li S, Ma Y, Lin J, Wan J, et al. The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease. Front Cardiovasc Med. 2023;10:1140215. https:\/\/doi.org\/10.3389\/fcvm.2023.1140215.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3043_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12933-021-01393-5","volume":"20","author":"L Fu","year":"2021","unstructured":"Fu L, Zhou Y, Sun J, Zhu Z, Xing Z, Zhou S, et al. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):201. https:\/\/doi.org\/10.1186\/s12933-021-01393-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3043_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12872-023-03451-0","volume":"23","author":"G Duiyimuhan","year":"2023","unstructured":"Duiyimuhan G, Maimaiti N. The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES. BMC Cardiovasc Disord. 2023;23(1):452. https:\/\/doi.org\/10.1186\/s12872-023-03451-0.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"3043_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12933-024-02370-4","volume":"23","author":"FF You","year":"2024","unstructured":"You FF, Gao J, Gao YN, Li ZH, Shen D, Zhong WF, et al. Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population-based cohort study. Cardiovasc Diabetol. 2024;23(1):276. https:\/\/doi.org\/10.1186\/s12933-024-02370-4.","journal-title":"Cardiovasc Diabetol"},{"key":"3043_CR31","doi-asserted-by":"crossref","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023;147(8):e93-e621.10.1161\/CIR.0000000000001123.Erratum in: Circulation.2023;147(8):e622. doi: 10.1161\/CIR.0000000000001137. Erratum in: Circulation. 2023;148(4):e4. doi: 10.1161\/CIR.0000000000001167.","DOI":"10.1161\/CIR.0000000000001167"},{"key":"3043_CR32","doi-asserted-by":"publisher","unstructured":"Wu J, Zhou Q, Wei Z, Wei J, Cui M. Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis. Front Cardiovasc Med. 2021;8:817441. doi: 10.3389\/fcvm.2021.817441. Erratum in: Front Cardiovasc Med. 2023;10:1153914. https:\/\/doi.org\/10.3389\/fcvm.2023.1153914","DOI":"10.3389\/fcvm.2023.1153914"},{"key":"3043_CR33","doi-asserted-by":"publisher","first-page":"1405828","DOI":"10.3389\/fendo.2024.1405828","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Lu C, Ju H, Zhou Q, Zhao X. Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017\u20132018. Front Endocrinol (Lausanne). 2024;15:1405828. https:\/\/doi.org\/10.3389\/fendo.2024.1405828.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3043_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12933-024-02198-y","volume":"23","author":"M Rabiee Rad","year":"2024","unstructured":"Rabiee Rad M, Ghasempour Dabaghi G, Darouei B, Amani-Beni R. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Cardiovasc Diabetol. 2024;23(1):119. https:\/\/doi.org\/10.1186\/s12933-024-02198-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3043_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12933-025-02716-6","volume":"24","author":"Z Song","year":"2025","unstructured":"Song Z, Miao X, Liu S, Hu M, Xie X, Sun Y, et al. Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study. Cardiovasc Diabetol. 2025;24(1):154. https:\/\/doi.org\/10.1186\/s12933-025-02716-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"9771","key":"3043_CR36","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","volume":"377","author":"D Wormser","year":"2011","unstructured":"Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085\u201395. https:\/\/doi.org\/10.1016\/S0140-6736(11)60105-0.","journal-title":"Lancet"},{"issue":"1","key":"3043_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-022-01729-9","volume":"21","author":"X Tian","year":"2022","unstructured":"Tian X, Chen S, Wang P, Xu Q, Zhang Y, Luo Y, et al. Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):289. https:\/\/doi.org\/10.1186\/s12933-022-01729-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3043_CR38","doi-asserted-by":"publisher","first-page":"m3324","DOI":"10.1136\/bmj.m3324","volume":"370","author":"A Jayedi","year":"2020","unstructured":"Jayedi A, Soltani S, Zargar MS, Khan TA, Shab-Bidar S. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ. 2020;370:m3324. https:\/\/doi.org\/10.1136\/bmj.m3324.","journal-title":"BMJ"},{"issue":"1","key":"3043_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12944-021-01617-3","volume":"21","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang W. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. Lipids Health Dis. 2022;21(1):8. https:\/\/doi.org\/10.1186\/s12944-021-01617-3.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3043_CR40","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1038\/s41598-024-64034-3","volume":"14","author":"L Yan","year":"2024","unstructured":"Yan L, Hu X, Wu S, Cui C, Zhao S. Association between the cardiometabolic index and NAFLD and fibrosis. Sci Rep. 2024;14(1):13194. https:\/\/doi.org\/10.1038\/s41598-024-64034-3.","journal-title":"Sci Rep"},{"issue":"1","key":"3043_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12944-024-02027-x","volume":"23","author":"WF Xi","year":"2024","unstructured":"Xi WF, Yang AM. Association between cardiometabolic index and controlled Attenuation parameter in U.S. Adults with NAFLD: findings from NHANES (2017\u20132020). Lipids Health Dis. 2024;23(1):40. https:\/\/doi.org\/10.1186\/s12944-024-02027-x.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3043_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12872-025-04950-y","volume":"25","author":"X Wu","year":"2025","unstructured":"Wu X, Wu M, Huang H, Liu Z, Huang H, Wang L. Association between cardiometabolic index and coronary artery calcification in young and middle-aged adults with coronary heart disease. BMC Cardiovasc Disord. 2025;25(1):487. https:\/\/doi.org\/10.1186\/s12872-025-04950-y.","journal-title":"BMC Cardiovasc Disord"},{"key":"3043_CR43","doi-asserted-by":"publisher","first-page":"119940","DOI":"10.1016\/j.jad.2025.119940","volume":"391","author":"X Cui","year":"2025","unstructured":"Cui X, Zhang Y, Jin Y, Wu Z, Gao Y, Su H, et al. Association of cardiometabolic index and depressive symptoms with cardiovascular and cerebrovascular diseases in middle-aged and older adults: A National prospective cohort study. J Affect Disord. 2025;391:119940. https:\/\/doi.org\/10.1016\/j.jad.2025.119940. Epub 2025 Jul 18.","journal-title":"J Affect Disord"},{"issue":"1","key":"3043_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s40200-024-01530-3","volume":"24","author":"X Huang","year":"2024","unstructured":"Huang X, Wen S, Huang Y, Zhang B, Xia Z, Huang Z. Association between cardiometabolic index and the incidence of stroke: a prospective nationwide cohort study in China. J Diabetes Metab Disord. 2024;24(1):26. https:\/\/doi.org\/10.1007\/s40200-024-01530-3.","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"3043_CR45","doi-asserted-by":"publisher","first-page":"17831","DOI":"10.1038\/s41598-025-01848-9","volume":"15","author":"M Ren","year":"2025","unstructured":"Ren M, Shen Y, Yuan Y, Han Z, Zhong Y, Liu S. Association between cardiometabolic index and abdominal aortic calcification in US adults from the NHANES. Sci Rep. 2025;15(1):17831. https:\/\/doi.org\/10.1038\/s41598-025-01848-9.","journal-title":"Sci Rep"},{"issue":"4","key":"3043_CR46","doi-asserted-by":"publisher","first-page":"e70044","DOI":"10.1002\/dmrr.70044","volume":"41","author":"C Liu","year":"2025","unstructured":"Liu C, Zhang Z, Meng T, Wang B, Li C, Yu X, et al. The impact of cardiometabolic index on cardiovascular disease risk among diabetic patients: evidence from two National cohorts. Diabetes Metab Res Rev. 2025;41(4):e70044. https:\/\/doi.org\/10.1002\/dmrr.70044.","journal-title":"Diabetes Metab Res Rev"},{"key":"3043_CR47","doi-asserted-by":"publisher","unstructured":"Liu D, Wang X, Tian Z, Lei YL, Zhou Q, Duan L et al. Association between the cardiometabolic index and mortality risk in US adults: Data from the National Health and Nutrition Examination Survey (NHANES) 1999\u20132018. J Clin Lipidol. 2025 Sep-Oct;19(5):1284\u20131291. doi: 10.1016\/j.jacl.2025.06.019. Epub 2025 Jun 28. Erratum in: J Clin Lipidol. 2025 Oct 18:S1933-2874(25)00399-X. https:\/\/doi.org\/10.1016\/j.jacl.2025.09.013","DOI":"10.1016\/j.jacl.2025.09.013"},{"issue":"3","key":"3043_CR48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.21037\/cdt-2025-100","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ferdinand KC, Gazzaruso C, Horowitz JD, Ren M. Association between the cardiometabolic index and all-cause and cardiovascular mortality in diabetes and prediabetes. Cardiovasc Diagn Ther. 2025;15(3):635\u201352. https:\/\/doi.org\/10.21037\/cdt-2025-100. Epub 2025 Jun 24.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"30","key":"3043_CR49","doi-asserted-by":"publisher","first-page":"e43532","DOI":"10.1097\/MD.0000000000043532","volume":"104","author":"C Huang","year":"2025","unstructured":"Huang C, Chen L. Association of cardiometabolic index with all-cause and cause-specific mortality among U.S. Adult population: A longitudinal cohort study. Med (Baltim). 2025;104(30):e43532. https:\/\/doi.org\/10.1097\/MD.0000000000043532.","journal-title":"Med (Baltim)"},{"issue":"6","key":"3043_CR50","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/medicina61061064","volume":"61","author":"D Yang","year":"2025","unstructured":"Yang D, Li W, Luo W, Yang Y, Yi J, Li C, et al. Association between cardiometabolic index and mortality among patients with atherosclerotic cardiovascular disease: evidence from NHANES 1999\u20132018. Med (Kaunas). 2025;61(6):1064. https:\/\/doi.org\/10.3390\/medicina61061064.","journal-title":"Med (Kaunas)"},{"issue":"1","key":"3043_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12944-024-02408-2","volume":"23","author":"M Liu","year":"2024","unstructured":"Liu M, Wang C, Liu R, Wang Y, Wei B. Association between cardiometabolic index and all-cause and cause-specific mortality among the general population: NHANES 1999\u20132018. Lipids Health Dis. 2024;23(1):425. https:\/\/doi.org\/10.1186\/s12944-024-02408-2.","journal-title":"Lipids Health Dis"},{"key":"3043_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. https:\/\/doi.org\/10.1186\/1471-230X-6-33.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"3043_CR53","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201\u20134. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.031. Epub 2013 Jan 22.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"3043_CR54","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","volume":"3","author":"H Tilg","year":"2021","unstructured":"Tilg H, Adolph TE, Dudek M, Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab. 2021;3(12):1596\u2013607. https:\/\/doi.org\/10.1038\/s42255-021-00501-9.","journal-title":"Nat Metab"},{"issue":"1","key":"3043_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1\u20134. https:\/\/doi.org\/10.1172\/JCI92035. Epub 2017 Jan 3.","journal-title":"J Clin Invest"},{"key":"3043_CR56","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107 E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021;119:154770. https:\/\/doi.org\/10.1016\/j.metabol.2021.154770.","journal-title":"Metabolism"},{"issue":"2","key":"3043_CR57","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jhep.2016.09.022","volume":"66","author":"J Ma","year":"2017","unstructured":"Ma J, Hwang SJ, Pedley A, Massaro JM, Hoffmann U, Chung RT, et al. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. J Hepatol. 2017;66(2):390\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2016.09.022.","journal-title":"J Hepatol"},{"issue":"36","key":"3043_CR58","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.3748\/wjg.v28.i36.5364","volume":"28","author":"SJ Duan","year":"2022","unstructured":"Duan SJ, Ren ZY, Zheng T, Peng HY, Niu ZH, Xia H, et al. Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease. World J Gastroenterol. 2022;28(36):5364\u201379. https:\/\/doi.org\/10.3748\/wjg.v28.i36.5364.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3043_CR59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12944-019-1112-6","volume":"18","author":"F Xie","year":"2019","unstructured":"Xie F, Zhou H, Wang Y. Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population. Lipids Health Dis. 2019;18(1):170. https:\/\/doi.org\/10.1186\/s12944-019-1112-6.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"3043_CR60","doi-asserted-by":"publisher","first-page":"e70132","DOI":"10.1002\/edm2.70132","volume":"8","author":"DM Miller","year":"2025","unstructured":"Miller DM, McCauley KF, Dunham-Snary KJ. Metabolic Dysfunction-Associated steatotic liver disease (MASLD): Mechanisms, clinical implications and therapeutic advances. Endocrinol Diabetes Metab. 2025;8(6):e70132. https:\/\/doi.org\/10.1002\/edm2.70132.","journal-title":"Endocrinol Diabetes Metab"},{"key":"3043_CR61","doi-asserted-by":"publisher","first-page":"101046","DOI":"10.1016\/j.ajpc.2025.101046","volume":"23","author":"J Li","year":"2025","unstructured":"Li J, Wei X. Baseline and changes in cardiometabolic index and incident cardiovascular disease in two prospective cohorts. Am J Prev Cardiol. 2025;23:101046. https:\/\/doi.org\/10.1016\/j.ajpc.2025.101046.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"3043_CR62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12872-025-04918-y","volume":"25","author":"DG Mo","year":"2025","unstructured":"Mo DG, Liu T, Bai JX, Liu M, Han QF, Yao HC. Association between the cardiometabolic index and cardiovascular disease risk in patients with cardiovascular-kidney-metabolic syndrome: a cohort study. BMC Cardiovasc Disord. 2025;25(1):451. https:\/\/doi.org\/10.1186\/s12872-025-04918-y.","journal-title":"BMC Cardiovasc Disord"},{"key":"3043_CR63","doi-asserted-by":"publisher","first-page":"1516591","DOI":"10.3389\/fcvm.2025.1516591","volume":"12","author":"F Chen","year":"2025","unstructured":"Chen F, Niu Y, Wu R, Jiang H, Zhu J, Wang C, et al. Association between cardiometabolic index and cardiovascular disease: evidence from the NHANES 2007\u20132018. Front Cardiovasc Med. 2025;12:1516591. https:\/\/doi.org\/10.3389\/fcvm.2025.1516591.","journal-title":"Front Cardiovasc Med"},{"issue":"15","key":"3043_CR64","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1039\/d5fo01237f","volume":"16","author":"R Yang","year":"2025","unstructured":"Yang R, Pang J, Zhong X, Pang S, Hu X, Wei C, et al. Molecular mechanisms of aberrant fatty acids metabolism in driving cardiovascular diseases: key regulatory targets and dietary interventions. Food Funct. 2025;16(15):5961\u201393. https:\/\/doi.org\/10.1039\/d5fo01237f.","journal-title":"Food Funct"},{"issue":"17","key":"3043_CR65","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. https:\/\/doi.org\/10.3390\/ijms21176275.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3043_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12933-025-02901-7","volume":"24","author":"T Li","year":"2025","unstructured":"Li T, Yi Z, Huang Y, Tan Y, Gao S, Wang T, et al. Prognostic value of triglyceride-glucose index combined with stress hyperglycemia ratio for all-cause mortality in critically ill patients with stroke. Cardiovasc Diabetol. 2025;24(1):337. https:\/\/doi.org\/10.1186\/s12933-025-02901-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3043_CR67","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-024-02228-9","volume":"23","author":"H Yan","year":"2024","unstructured":"Yan H, Zhou Q, Wang Y, Tu Y, Zhao Y, Yu J, et al. Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2024;23(1):142. https:\/\/doi.org\/10.1186\/s12933-024-02228-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3043_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12933-023-01886-5","volume":"22","author":"B Yin","year":"2023","unstructured":"Yin B, Wu Z, Xia Y, Xiao S, Chen L, Li Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22(1):157. https:\/\/doi.org\/10.1186\/s12933-023-01886-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3043_CR69","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12933-025-02618-7","volume":"24","author":"L Jiang","year":"2025","unstructured":"Jiang L, Zhu T, Song W, Zhai Y, Tang Y, Ruan F, et al. Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):56. https:\/\/doi.org\/10.1186\/s12933-025-02618-7.","journal-title":"Cardiovasc Diabetol"},{"key":"3043_CR70","doi-asserted-by":"publisher","first-page":"1341828","DOI":"10.3389\/fendo.2024.1341828","volume":"15","author":"J Song","year":"2024","unstructured":"Song J, Li Y, Zhu J, Liang J, Xue S, Zhu Z. Non-linear associations of cardiometabolic index with insulin resistance, impaired fasting glucose, and type 2 diabetes among US adults: a cross-sectional study. Front Endocrinol (Lausanne). 2024;15:1341828. https:\/\/doi.org\/10.3389\/fendo.2024.1341828.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"3043_CR71","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.3390\/ijms23095089","volume":"23","author":"S P\u0142aczkowska","year":"2022","unstructured":"P\u0142aczkowska S, So\u0142kiewicz K, Bednarz-Misa I, Kratz EM. Atherogenic plasma index or Non-High-Density lipoproteins as markers best reflecting Age-Related high concentrations of small dense Low-Density lipoproteins. Int J Mol Sci. 2022;23(9):5089. https:\/\/doi.org\/10.3390\/ijms23095089.","journal-title":"Int J Mol Sci"},{"key":"3043_CR72","doi-asserted-by":"publisher","first-page":"1207537","DOI":"10.3389\/fendo.2023.1207537","volume":"14","author":"J Zhu","year":"2023","unstructured":"Zhu J, Jiang Y. Editorial: the role of diabetes in the pathophysiology and prognosis of ischemic stroke. Front Endocrinol (Lausanne). 2023;14:1207537. https:\/\/doi.org\/10.3389\/fendo.2023.1207537.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3043_CR73","doi-asserted-by":"publisher","first-page":"100301","DOI":"10.1016\/j.clinsp.2023.100301","volume":"78","author":"SH Tan","year":"2023","unstructured":"Tan SH, Zhou XL. Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation. Clin (Sao Paulo). 2023;78:100301. https:\/\/doi.org\/10.1016\/j.clinsp.2023.100301.","journal-title":"Clin (Sao Paulo)"},{"key":"3043_CR74","doi-asserted-by":"publisher","first-page":"106175","DOI":"10.1016\/j.cct.2020.106175","volume":"98","author":"T Hardy","year":"2020","unstructured":"Hardy T, Wonders K, Younes R, Aithal GP, Aller R, Allison M, et al. The European NAFLD registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. Contemp Clin Trials. 2020;98:106175. https:\/\/doi.org\/10.1016\/j.cct.2020.106175. Epub 2020 Oct 9.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"3043_CR75","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng L, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232. https:\/\/doi.org\/10.1186\/s12933-024-02343-7.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-03043-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:56:19Z","timestamp":1772621779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-025-03043-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3043"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-03043-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHANES was conducted with approval by the National Center for Health Statistics Ethics Review Board, and obtained informed written consent from all the individuals involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}